ACTIVE

PR PHARMACEUTICALS

Financial year 2025 · Closed on 31/12/2025

Net result-11,5 k €-28,3 %over 1 year

Gross margin-230,4 €-10,9 %over 1 year

Equity-288,6 k €-4,2 %over 1 year

Identity

Source · BCE/KBO

PR PHARMACEUTICALS is a Public limited company incorporated in 1999. Its main activity is: Management consultancy activities. Its registered office is in Hoogstraten.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0465.770.145
Incorporation: 01/04/1999
Legal form: Public limited company
Registered office: Langenberg 41
2323 Hoogstraten · FlandreSee on map
Contributed capital: 66 255,64 €
Latest accounts: 31/12/2025

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 74142Specialised design activities

Financials

Source · NBB, 19 filings

Trend over 19 financial years

	2025		2024		2022		2021		2020
Income statement
Gross margin	-230,4 €	-10.9%	-207,7 €	+70.7%	-709,8 €	-485%	184,5 €	-99.8%	75,9 k €
EBITDA	-350,4 €	+54.5%	-770 €	+33.6%	-1,2 k €	+51.4%	-2,4 k €	-103%	74,7 k €
Operating result	-350,4 €	+54.5%	-770 €	+33.6%	-1,2 k €	+51.4%	-2,4 k €	-103%	74,7 k €
Net result	-11,5 k €	-28.3%	-9 k €	-354%	3,5 k €	+108%	1,7 k €	-97.6%	71,8 k €
Balance sheet
Equity	-288,6 k €	-4.2%	-277,1 k €	-248%	187,2 k €	+1.9%	183,6 k €	+0.9%	181,9 k €
Total assets	19,7 k €	+2.7%	19,2 k €	-90.5%	200,8 k €	+1.5%	197,9 k €	+2.5%	193,1 k €
Cash	30,7 €	+780%	3,5 €	-95.4%	75,9 €	-86.7%	571,6 €	+12.9%	506,4 €
Debts	308,3 k €	+4.1%	296,3 k €	+2071%	13,6 k €	-4.1%	14,2 k €	+27.7%	11,2 k €

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
LUDO TIELEN	Managing director01/03/2021 → 07/06/2027Director24/04/2012 → 2021 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Alexander Michiels	Managing director01/07/2013 → 2013 accounts
Patrick Bols	Directorlisted until the 2011 accountsManaging director24/04/2012 → 2012 accounts

Other companies at this address

Langenberg 41 2323 Hoogstraten

Company	CBE no.
Bouwinvest Essen● Active	0893.517.577
Colanda● Active	0881.075.051
DE DIEPT● Active	0447.660.938
EASTERN● Active	0443.847.749
HMK-HOLTRANS● Active	0454.566.843
I.D. Vastgoed● Active	0431.713.445
Intermedia● Active	0419.954.372
Kaya Finance● Active	1017.597.801
Oversea Invest● Active	0808.100.169
R.W.H.● Active	0434.315.619
Tapramo● Active	0881.068.222
'T HOFKE● Active	0433.937.715
V.V. INVEST● Active	0870.694.863
YACELO● Active	0427.811.669
YCL● Active	1024.425.215

Full financial information

Source · NBB

	2025	2024	2022	2021	2020	2019
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2025	31/12/2024	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	20/07/2026	25/09/2025	31/08/2023	11/07/2022	31/08/2021	16/07/2020
General meeting	25/06/2026	26/08/2025	30/06/2023	06/06/2022	31/07/2021	30/06/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	25/06/2026	20/07/2026	Dutch	PDF
Micro model	31/12/2024	26/08/2025	25/09/2025	Dutch	PDF
Micro model	31/12/2022	30/06/2023	31/08/2023	Dutch	PDF
Micro model	31/12/2021	06/06/2022	11/07/2022	Dutch	PDF
Micro model	31/12/2020	31/07/2021	31/08/2021	Dutch	PDF
Micro model	31/12/2019	30/06/2020	16/07/2020	Dutch	PDF
Micro model	31/12/2018	30/06/2019	31/07/2019	Dutch	PDF
Abridged model	31/12/2017	25/07/2018	24/08/2018	Dutch	PDF
Abridged model	31/12/2016	30/08/2017	05/10/2017	Dutch	PDF
Abridged model	31/12/2015	06/06/2016	28/07/2016	Dutch	PDF
Abridged model	31/12/2014	30/06/2015	27/07/2015	Dutch	PDF
Abridged model	31/12/2013	30/06/2014	18/07/2014	Dutch	PDF
Abridged model	31/12/2012	30/06/2013	25/07/2013	Dutch	PDF
Abridged model	31/12/2011	15/07/2012	16/08/2012	Dutch	PDF
Abridged model	31/12/2010	10/07/2011	09/08/2011	Dutch	PDF
Abridged model	31/12/2009	30/06/2010	28/07/2010	Dutch	PDF
Abridged model	31/12/2008	30/06/2009	13/07/2009	Dutch	PDF
Abridged model	31/12/2007	25/06/2008	24/07/2008	Dutch	PDF
Abridged model	31/12/2006	30/06/2007	07/08/2007	Dutch	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
LUDO TIELEN	Managing director01/03/2021 → 07/06/2027Director24/04/2012 → 2021 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Alexander Michiels	Managing director01/07/2013 → 2013 accounts
Patrick Bols	Directorlisted until the 2011 accountsManaging director24/04/2012 → 2012 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates22/04/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/02/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/08/2013
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/07/2006
“ Ontslag bestuurders - wijziging maatschappelijke zetel
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings19 filings

Mandates

LUDO TIELEN

Alexander Michiels

Patrick Bols

Steve Howe

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

PR PHARMACEUTICALS

Langenberg 41, 2323 Wortel

Managing directorDirector

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Langenberg 41, 2323 WortelCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00310356

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
PR PHARMACEUTICALSCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00310356

Events

2025
Annual accounts 2025-11,5 k €↓
2024
Annual accounts 2024-9 k €↓
2022
Annual accounts 20223,5 k €↑
2021
Annual accounts 20211,7 k €↓
2020
Annual accounts 202071,8 k €↑
2019
Annual accounts 201919,1 k €↑
2018
Annual accounts 2018-23,5 k €↓
2017
Annual accounts 2017-7,9 k €↓
2016
Annual accounts 2016114,9 k €↓
2015
Annual accounts 2015247,4 k €↑
2014
Annual accounts 2014130,9 k €↑
2013
Annual accounts 2013-493,1 k €↓
2012
Annual accounts 2012-403,1 €↑
2011
Annual accounts 2011-1,5 k €↓
2010
Annual accounts 20102,4 k €↑
2009
Annual accounts 2009-3,6 k €↑
2008
Annual accounts 2008-3,9 k €↓
2007
Annual accounts 2007-3,1 k €↑
2006
Annual accounts 2006-7,8 k €
01/04/1999
IncorporationPublic limited company

PR PHARMACEUTICALS

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events